Importance of Drug Pharmacokinetics at the Site of Action
about
Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-lactamase Inhibitor, Dosed in Combination with Imipenem/Cilastatin in Healthy Subjects.When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
P2860
Importance of Drug Pharmacokinetics at the Site of Action
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Importance of Drug Pharmacokinetics at the Site of Action
@ast
Importance of Drug Pharmacokinetics at the Site of Action
@en
type
label
Importance of Drug Pharmacokinetics at the Site of Action
@ast
Importance of Drug Pharmacokinetics at the Site of Action
@en
prefLabel
Importance of Drug Pharmacokinetics at the Site of Action
@ast
Importance of Drug Pharmacokinetics at the Site of Action
@en
P2093
P2860
P921
P356
P1476
Importance of Drug Pharmacokinetics at the Site of Action
@en
P2093
P2860
P304
P356
10.1111/CTS.12448
P407
P577
2017-02-03T00:00:00Z
2017-05-01T00:00:00Z